Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 3
2010 1
2011 2
2012 1
2013 2
2014 3
2015 4
2016 2
2017 2
2019 1
2020 4
2021 4
2022 2
2023 3
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Novel plasma and brain proteins that are implicated in multiple sclerosis.
Lin X, Yang Y, Gresle M, Cuellar-Partida G, Han X, Stankovich J; AusLong/Ausimmune Investigators Group; Simpson-Yap S, Fuh-Ngwa V, Charlesworth J, Burdon KP, Butzkueven H, Taylor BV, Zhou Y. Lin X, et al. Among authors: gresle m. Brain. 2023 Jun 1;146(6):2464-2475. doi: 10.1093/brain/awac420. Brain. 2023. PMID: 36346149
Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60.
Foong YC, Merlo D, Gresle M, Buzzard K, Zhong M, Yeh WZ, Jokubaitis V, Monif M, Skibina O, Ozakbas S, Patti F, Grammond P, Amato MP, Kalincik T, Horakova D, Kubala Havrdova E, Weinstock-Guttman B, Lechner Scott J, Boz C, Sa MJ, Butzkueven H, van der Walt A, Zhu C; MSBASE study group. Foong YC, et al. Among authors: gresle m. J Neurol Neurosurg Psychiatry. 2024 Mar 7:jnnp-2023-332883. doi: 10.1136/jnnp-2023-332883. Online ahead of print. J Neurol Neurosurg Psychiatry. 2024. PMID: 38453478
Prediction of multiple sclerosis outcomes when switching to ocrelizumab.
Zhong M, van der Walt A, Stankovich J, Kalincik T, Buzzard K, Skibina O, Boz C, Hodgkinson S, Slee M, Lechner-Scott J, Macdonell R, Prevost J, Kuhle J, Laureys G, Van Hijfte L, Alroughani R, Kermode AG, Butler E, Barnett M, Eichau S, van Pesch V, Grammond P, McCombe P, Karabudak R, Duquette P, Girard M, Taylor B, Yeh W, Monif M, Gresle M, Butzkueven H, Jokubaitis VG. Zhong M, et al. Among authors: gresle m. Mult Scler. 2022 May;28(6):958-969. doi: 10.1177/13524585211049986. Epub 2021 Oct 8. Mult Scler. 2022. PMID: 34623947
Epigenetic differences at the HTR2A locus in progressive multiple sclerosis patients.
Maltby VE, Lea RA, Burnard S, Xavier A, Van Cao T, White N, Kennedy D, Groen K, Sanders KA, Seeto R, Bray S, Gresle M, Laverick L, Butzkueven H, Scott RJ, Lechner-Scott J. Maltby VE, et al. Among authors: gresle m. Sci Rep. 2020 Dec 17;10(1):22217. doi: 10.1038/s41598-020-78809-x. Sci Rep. 2020. PMID: 33335118 Free PMC article.
37 results